Abiraterone acetate and prednisone in metastatic castration-resistant prostate cancer: a real-world retrospective study in China
Article in Frontiers in Endocrinology (May 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Effectiveness and safety of radium‐223 dichloride in patients with castration‐resistant prostate cancer and bone metastases in real‐world practice: A multi‐institutional study
Article in International Journal of Urology (October 2022)
Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel
Article in International Journal of Clinical Oncology (June 2022)